United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

  1. May 21, 2015

    Novartis Catches Flak For Clawback Bid In FCA Kickback Row

    A former Novartis Pharmaceutical Corp. employee has fired back at the drugmaker's discovery clawback efforts in a False Claims Act suit alleging drug referral kickbacks, telling a New York federal court that Novartis is withholding critical documents and improperly coaching deposition witnesses.

  2. May 07, 2015

    Feds Intervene Against Novartis After Co-Defendant Settles

    The federal government is now a plaintiff in a False Claims Act and Anti-Kickback suit alleging Novartis Pharmaceuticals Corp. participated in a patient kickback scheme, after a New York federal judge on Wednesday approved U.S. attorneys' motion to intervene.

  3. May 01, 2015

    Accredo To Pay $60M In Novartis Exjade Kickback Suit

    Specialty pharmacy Accredo Health Group Inc. will pay $14.9 million to resolve state regulators' claims it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp., U.S. Attorney Preet Bharara said Friday, on top of a $45 million settlement with federal authorities revealed Thursday.

  4. April 30, 2015

    Accredo Pays $45M To Escape Novartis Exjade Kickback Suit

    Specialty pharmacy Accredo Health Group Inc. agreed to pay $45 million to settle allegations it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp. involving refill prescriptions of an iron reduction drug, records filed Thursday in New York federal court show.

  5. April 01, 2015

    Novartis Docs Privileged In Kickback Case, Judge Says

    A New York federal magistrate judge on Tuesday rejected the U.S. government's attempt to force Novartis Pharmaceuticals Corp. to turn over documents detailing legal advice regarding its relationship with pharmacies dispensing the organ transplant medication Myfortic, finding the documents are privileged in a whistleblower suit over alleged kickbacks.

  6. March 27, 2015

    Reed Smith Atty To Testify On Novartis Kickback Advice

    A Reed Smith LLP partner who previously advised Novartis Pharmaceuticals Corp. on its compliance with anti-kickback laws will testify at an upcoming False Claims Act trial accusing the drugmaker of giving fraudulent rebates to pharmacies, a Novartis attorney said in New York federal court Friday.

  7. March 04, 2015

    Novartis Told To Produce Docs In Kickbacks Suit By March 13

    A New York federal judge on Wednesday ordered Novartis Pharmaceuticals Corp. to hand over unredacted documents and privilege logs by March 13, resolving for the moment a dispute over document deadlines in the False Claims Act suit alleging the company paid kickbacks to pharmacies.

  8. February 24, 2015

    Novartis Says Doc Deadline In FCA Suit Not Feasible

    Novartis Pharmaceuticals Corp. told a New York federal judge on Monday it would have to hire 40 more attorneys to work around the clock in order to meet a whistleblower's Friday deadline demand for documents in the False Claims Act suit alleging the company paid kickbacks to pharmacies.

  9. February 18, 2015

    Novartis Improperly Withholding Docs, Whistleblower Says

    A whistleblower on Wednesday asked a New York federal court to order his former employer, Novartis Pharmaceuticals Corp., to turn over its privilege log and produce documents he said were improperly withheld during discovery in a suit alleging the company paid kickbacks to pharmacies for pushing its products.

  10. January 13, 2015

    CVS Balks At Discovery Docs In Novartis Kickbacks Suit

    CVS Caremark Corp. asked a federal judge Monday for a protective order to prevent the whistleblower in a False Claims Act suit alleging it accepted kickbacks from Novartis Pharmaceuticals Corp. from responding to a discovery request with irrelevant documents.